Summary & Overview
CPT 88185: Flow Cytometry Technical Component, Additional Marker
CPT code 88185 represents the technical component of additional flow cytometry marker testing used to characterize cell populations by cell surface, cytoplasmic, or nuclear markers. As an add-on procedure code, 88185 is reported for each additional marker beyond the primary flow cytometry panel. This code matters nationally because flow cytometry is central to diagnosing hematologic cancers, monitoring immune disorders, and guiding targeted therapies; accurate coding supports clinical communication and appropriate laboratory billing.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the clinical context and service setting for 88185, common payer coverage considerations, and an outline of the benchmarks and policy topics typically reviewed for laboratory add-on codes. The publication summarizes national reimbursement patterns and utilization drivers for flow cytometry add-on testing, highlights clinical scenarios where additional markers are commonly required, and identifies policy updates and payer guidance that affect coding and payment for laboratory technical services.
The content is intended for billing managers, laboratory directors, and health policy analysts seeking an executive-level overview of CPT code 88185 and its implications for laboratory workflows and payer interactions.
Billing Code Overview
CPT code 88185 describes a flow cytometry, technical component performed by a laboratory analyst using cell surface, cytoplasmic, or nuclear markers to characterize cells. The procedure aids clinicians in diagnosing hematologic malignancies, immune dysfunctions, and other conditions where cellular phenotype is diagnostically relevant.
Service Type: Laboratory - Flow Cytometry, Technical Component
Typical Site of Service: Clinical laboratory or hospital laboratory
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with persistent lymphadenopathy and abnormal peripheral blood counts is referred by a hematologist to the clinical laboratory for flow cytometric immunophenotyping. A diagnostic specimen (peripheral blood and a bone marrow aspirate) is collected in the outpatient infusion center and sent to the lab. The laboratory technologist prepares and stains the sample with a primary antibody panel to identify major cell populations; additional markers are required to further characterize aberrant lymphoid populations. The lab analyst performs the technical component of the additional flow cytometry markers using cell surface and intracellular antibodies to refine lineage assignment and detect clonal populations, generating quantitative scatter and fluorescence data for the pathologist’s interpretation. The full workflow includes specimen accessioning, panel preparation, instrument setup and quality control, acquisition of additional marker data, data analysis and generation of raw outputs. The procedure supports diagnostic evaluation for conditions such as B‑cell or T‑cell lymphoproliferative disorders, minimal residual disease monitoring after therapy, and immune dysfunction evaluation in oncology or transplant patients. Typical sites of service include hospital-based clinical laboratories, independent reference laboratories, and outpatient pathology or hematology laboratories. The service type is a laboratory technical component for additional flow cytometry markers performed after the initial marker set represented by the primary flow cytometry code.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 |